Targeted Bioscience

Targeted Bioscience

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $9.5M

Overview

Targeted Bioscience is a private, commercial-stage company offering an integrated hardware and software platform for spatial profiling and digital pathology. Its core offerings include the Acculift™ Tissue Profiler for laser capture microdissection, the Targeted Labs Pro™ cloud platform for AI-driven data analysis and collaboration, and the Targeted EV™ kit for isolating extracellular vesicles from tissue. The company targets the growing research and diagnostic markets in oncology and spatial biology, providing tools to unlock molecular signatures from tissue with single-cell precision.

Oncology

Technology Platform

Integrated spatial biology ecosystem comprising: 1) Acculift™ laser capture microdissection (LCM) hardware for single-cell tissue profiling, 2) Targeted Labs Pro™ cloud platform for AI-driven digital pathology and multi-omic data analysis, and 3) Targeted EV™ kit for isolating extracellular vesicles from tissue interstitial fluid.

Funding History

2
Total raised:$9.5M
Series A$8M
Seed$1.5M

Opportunities

The company is positioned in the high-growth spatial biology and digital pathology markets.
Its integrated ecosystem addresses a key researcher need by bridging tissue visualization, precise sampling, and AI-powered multi-omic analysis in a single workflow.
Expansion through distribution partnerships and development of disease-specific AI applications present significant growth avenues.

Risk Factors

Intense competition from large, well-capitalized players in both spatial genomics and digital pathology poses a major threat.
The company faces technology adoption risk, as it must convince researchers to switch from established, best-in-class point solutions to its integrated platform.
Execution risk is high due to the challenges of scaling hardware manufacturing, software development, and global commercial operations simultaneously as a private company.

Competitive Landscape

Targeted Bioscience operates in a crowded and competitive landscape. In spatial profiling, it competes with leaders like 10x Genomics, Akoya Biosciences, and NanoString. In digital pathology software, it faces competition from Philips, Leica, Proscia, and Indica Labs. Its differentiation lies in its unique integration of LCM, EV isolation, and a cloud AI platform, offering a contiguous workflow that larger players with more fragmented portfolios may not provide.